Aspirin Use is Associated with Reduced Risk of Cholangiocarcinoma

被引:0
|
作者
Choi, Jonggi [1 ,2 ]
Ghoz, Hassan M. [1 ,2 ]
Peeraphatdit, Thoetchai [1 ,2 ,3 ]
Baichoo, Esha [1 ,2 ,4 ]
Addissie, Benyam D. [1 ,2 ]
Harmsen, William S. [5 ]
Therneau, Terry M. [5 ]
Olson, Janet E. [5 ,6 ]
Chaiteerakij, Roongruedee [1 ,2 ,7 ,8 ]
Roberts, Lewis R. [1 ,2 ]
机构
[1] Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Rochester, MN USA
[2] Mayo Clin, Ctr Canc, Rochester, MN USA
[3] Univ Minnesota, Dept Internal Med, Minneapolis, MN USA
[4] Mt Sinai Roosevelt Hosp, Dept Med, New York, NY USA
[5] Mayo Clin, Dept Biomed Stat & Informat, Rochester, MN USA
[6] Mayo Clin, Dept Hlth Sci Res, Div Epidemiol, Rochester, MN USA
[7] Chulalongkorn Univ, Fac Med, Dept Med, Bangkok 10330, Thailand
[8] King Chulalongkorn Mem Hosp, Thai Red Cross Soc, Bangkok, Thailand
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
397
引用
收藏
页码:410A / 411A
页数:2
相关论文
共 50 条
  • [22] Reduced Hepatocellular Carcinoma Risk vs Bleeding Risk Associated With Aspirin Reply
    Simon, Tracey G.
    Chan, Andrew T.
    JAMA ONCOLOGY, 2019, 5 (06) : 911 - 912
  • [23] Daily Aspirin Use Associated With Reduced Risk for Fibrosis Progression in Patients With Nonalcoholic Fatty Liver Disease
    Severo, Mateus Dornelles
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (02) : 523 - 523
  • [24] Daily Aspirin Use Associated With Reduced Risk For Fibrosis Progression In Patients With Nonalcoholic Fatty Liver Disease
    Simon, Tracey G.
    Henson, Jacqueline
    Osganian, Stephanie
    Masia, Ricard
    Chan, Andrew T.
    Chung, Raymond T.
    Corey, Kathleen E.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (13) : 2776 - +
  • [25] Cholangiocarcinoma risk factors and the potential role of aspirin
    Bagante, Fabio
    Gamblin, T. Clark
    Pawlik, Timothy M.
    HEPATOLOGY, 2016, 64 (03) : 708 - 710
  • [26] Aspirin Use Is Associated With a Lower Risk of Serrated Adenomas
    Lasa, Juan S.
    Leibovich, Natalia
    Ahumada, Maria C.
    Jeannot, Joaquin
    Trelles, Felix A.
    Caniggia, Diego
    Villarroel, Mariano
    Di Paola, Leandro E.
    Berman, Saul S.
    Zagalsky, David
    GASTROINTESTINAL ENDOSCOPY, 2016, 83 (05) : AB413 - AB413
  • [27] Risk Factors for Intrahepatic Cholangiocarcinoma: Association Between Metformin Use and Reduced Cancer Risk
    Chaiteerakij, Roongruedee
    Yang, Ju Dong
    Harmsen, William S.
    Slettedahl, Seth W.
    Mettler, Teresa A.
    Fredericksen, Zachary S.
    Kim, W. Ray
    Gores, Gregory J.
    Roberts, Rosebud O.
    Olson, Janet E.
    Therneau, Terry M.
    Roberts, Lewis R.
    HEPATOLOGY, 2013, 57 (02) : 648 - 655
  • [28] Gastric cancer risk in the elderly is associated with omeprazole use and inversely associated with aspirin use
    Gingold-Belfer, Rachel
    Issa, Nidal
    Boltin, Doron
    Beloosesky, Yichayaou
    Koren-Morag, Nira
    Meyerovitch, Joseph
    Sharon, Eran
    Peleg, Noam
    Schmilovitz-Weiss, Hemda
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2023, 35 (09) : 968 - 973
  • [29] Cerebral Microbleeds Evidence of Heightened Risk Associated With Aspirin Use
    Gorelick, Philip B.
    ARCHIVES OF NEUROLOGY, 2009, 66 (06) : 691 - 693
  • [30] Is Low-Dose Aspirin Use Associated With a Reduced Risk of Colorectal Cancer? A Qresearch Primary Care Database Analysis
    Logan, Richard E.
    Vinogradova, Yana
    Coupland, Carol A.
    Hippisley-Cox, Julia
    GASTROENTEROLOGY, 2011, 140 (05) : S402 - S402